These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31811138)

  • 1. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
    Morisaka H; Yoshimi K; Okuzaki Y; Gee P; Kunihiro Y; Sonpho E; Xu H; Sasakawa N; Naito Y; Nakada S; Yamamoto T; Sano S; Hotta A; Takeda J; Mashimo T
    Nat Commun; 2019 Dec; 10(1):5302. PubMed ID: 31811138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compact Cascade-Cas3 system for targeted genome engineering.
    Csörgő B; León LM; Chau-Ly IJ; Vasquez-Rifo A; Berry JD; Mahendra C; Crawford ED; Lewis JD; Bondy-Denomy J
    Nat Methods; 2020 Dec; 17(12):1183-1190. PubMed ID: 33077967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems.
    Tan R; Krueger RK; Gramelspacher MJ; Zhou X; Xiao Y; Ke A; Hou Z; Zhang Y
    Mol Cell; 2022 Feb; 82(4):852-867.e5. PubMed ID: 35051351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introducing Large Genomic Deletions in Human Pluripotent Stem Cells Using CRISPR-Cas3.
    Hou Z; Hu C; Ke A; Zhang Y
    Curr Protoc; 2022 Feb; 2(2):e361. PubMed ID: 35129865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a.
    Strohkendl I; Saifuddin FA; Rybarski JR; Finkelstein IJ; Russell R
    Mol Cell; 2018 Sep; 71(5):816-824.e3. PubMed ID: 30078724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome editing in mammalian cells using the CRISPR type I-D nuclease.
    Osakabe K; Wada N; Murakami E; Miyashita N; Osakabe Y
    Nucleic Acids Res; 2021 Jun; 49(11):6347-6363. PubMed ID: 34076237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex gene editing and large DNA fragment deletion by the CRISPR/Cpf1-RecE/T system in Corynebacterium glutamicum.
    Zhao N; Li L; Luo G; Xie S; Lin Y; Han S; Huang Y; Zheng S
    J Ind Microbiol Biotechnol; 2020 Aug; 47(8):599-608. PubMed ID: 32876764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tryptophan 'Gate' in the CRISPR-Cas3 Nuclease Controls ssDNA Entry into the Nuclease Site, That When Removed Results in Nuclease Hyperactivity.
    He L; Matošević ZJ; Mitić D; Markulin D; Killelea T; Matković M; Bertoša B; Ivančić-Baće I; Bolt EL
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference.
    Hochstrasser ML; Taylor DW; Bhat P; Guegler CK; Sternberg SH; Nogales E; Doudna JA
    Proc Natl Acad Sci U S A; 2014 May; 111(18):6618-23. PubMed ID: 24748111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual CRISPR-Cas3 system for inducing multi-exon skipping in DMD patient-derived iPSCs.
    Kita Y; Okuzaki Y; Naoe Y; Lee J; Bang U; Okawa N; Ichiki A; Jonouchi T; Sakurai H; Kojima Y; Hotta A
    Stem Cell Reports; 2023 Sep; 18(9):1753-1765. PubMed ID: 37625413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct Subcellular Localization of a Type I CRISPR Complex and the Cas3 Nuclease in Bacteria.
    Govindarajan S; Borges A; Karambelkar S; Bondy-Denomy J
    J Bacteriol; 2022 May; 204(5):e0010522. PubMed ID: 35389256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells.
    Li T; Zhu L; Xiao B; Gong Z; Liao Q; Guo J
    Biotechnol Adv; 2019; 37(1):21-27. PubMed ID: 30399413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing.
    Wang L; Wang H; Liu H; Zhao Q; Liu B; Wang L; Zhang J; Zhu J; Bao R; Luo Y
    Biotechnol Bioeng; 2019 Jun; 116(6):1463-1474. PubMed ID: 30730047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
    Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
    Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing in plants with MAD7 nuclease.
    Lin Q; Zhu Z; Liu G; Sun C; Lin D; Xue C; Li S; Zhang D; Gao C; Wang Y; Qiu JL
    J Genet Genomics; 2021 Jun; 48(6):444-451. PubMed ID: 34120856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas12a System for Biosensing and Gene Regulation.
    Shi Y; Fu X; Yin Y; Peng F; Yin X; Ke G; Zhang X
    Chem Asian J; 2021 Apr; 16(8):857-867. PubMed ID: 33638271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.